TNF and rheumatoid arthritis: R4RA is the first biopsy-driven, multicentre, randomised trial comparing tocilizumab with rituximab in patients with rheumatoid arthritis who had inadequate responses to anti-TNF drugs stratified for synovial B-cell status.